KLRK1 and neoplasm: Moreover, analysis of harvested tumor tissues showed that combination of VPA and NKG2D CAR-T treatment remarkably enhanced T cells infiltration into tumor sites as shown by increased CD3+ T cells (P < 0.005) in tumor tissues (Figure 5D; Supplementary Figure S1E).